Review found differences in estimated treatments for chlamydia and gonorrhea despite CDC guidelines

Published Date: 02 Mar 2023

A review of chlamydia and gonorrhea prevention studies conducted by the Regenstrief Institute found that rates of presumptive treatment (antibiotics before diagnosis) varied.

Read Full News

Latest News

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Neurological Effects of Ebola Persist Years After Infection

Despite partial recovery, neurological symptoms persist for years after infection in some adult survivors of Ebola, a prospective study showed.

In Congo, Doctors Face Ebola With Little Protection

Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo.

Congo Says Number Of Confirmed Ebola Cases Rises to Nearly 600

The Democratic Republic of Congo on Tuesday said confirmed Ebola cases had climbed to nearly 600, ⁠raising awareness within the local population about the importance of...

US Announces Additional $20 Million for Ebola Response

The U.S. State Department ⁠said on Wednesday it would provide ⁠an additional $20 million to help fight ⁠the Ebola ‌outbreak in Africa, bringing its total direct support to...

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Latest News

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Despite partial recovery, neurological symptoms persist for years after infection in some adult survivors of Ebola, a prospective study showed.

Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo.

The Democratic Republic of Congo on Tuesday said confirmed Ebola cases had climbed to nearly 600, ⁠raising awareness within the local population about the importance of...

The U.S. State Department ⁠said on Wednesday it would provide ⁠an additional $20 million to help fight ⁠the Ebola ‌outbreak in Africa, bringing its total direct support to...

News All Time

Flesh-eating Screwworm Found Within 31 Miles of US Border, Says USDA

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

Trump Signs Order to Use HHS Vaccine Assessment as Federal Guide

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

US Regulator Approves Oral Drug From Japan's Shionogi to Prevent COVID-19

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

Deep Dive: Reducing CV Risk Beyond LDL in Secondary Prevention

The 2026 ACC/AHA Dyslipidemia Guideline has set a numerical LDL-C target for secondary prevention. Now what?

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

FDA Advisers Recommend COVID Vaccines Be Updated to Target Current Dominant Variant

The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for 2026-2027 immunization should be updated to target ⁠the dominant XFG variant, despite some...

Medicine Renamed Many Diseases: Why Rename PCOS?

The proposed PMOS terminology reframes PCOS by emphasizing the psychological, dermatologic, reproductive, and metabolic features linked to the condition.

US CDC Seeks Staff for Ebola Screening as Outbreak Response Expands

The U.S. Centers for Disease Control and Prevention has asked staff to volunteer for urgent deployment to support ⁠Ebola screening at the country's entry points, according...

mRNA Shot Offers Efficacy for Influenza-Like Illness

In older adults, a single dose of the mRNA-1010 vaccine shows superior efficacy to the standard-dose inactivated seasonal influenza vaccine in the prevention of influenza-like illness.

Red Cross Mourns Death of Three Volunteers From Ebola

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

US Adds Atlanta Area Airport for Ebola Screening, CDC Says

Americans coming back from the Democratic Republic of the Congo, ⁠Uganda or South Sudan now have a second entry point for returning ⁠to the United States, with the CDC on...

US FDA Advisers to Weigh Updating 2026-27 COVID Vaccines for XFG Variant

Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG ⁠subvariant for the 2026-27...

Shingles Shot Shows Short-Term Safety in People With HIV

In people living with HIV, the adjuvanted recombinant subunit herpes zoster vaccine shows a favorable short-term safety and tolerability profile.

Inside an African Lab That Helped Crack the Hantavirus Outbreak

(Clarifies status of Istitut Pasteur de Dakar in paragraphs 6, 8-9)

Chikungunya in Pregnancy Raises Infant Hospital Risk

A cohort study of births in Brazil found increased hospitalization risk through age 3 after maternal chikungunya; results inform global surveillance and vaccination strategies.

US Working With Small Biotech Firm on Experimental Ebola Treatment, HHS Official Says

U.S. officials are working with Mapp Biopharmaceutical to make an experimental Ebola treatment available for people who may have been exposed to ⁠the virus, an HHS official...

Recommended News For You

To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.

Is Laughter Good for Blood Glucose Control?

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

New BCMA-Directed Therapies Show Promise in Multiple Myeloma

Only 1 in 4 Eligible Adults Receive Lung Screening

T-DXd Reduces Residual Disease in Early Breast Cancer

Recommended Articles For You

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice 

Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond 

Comprehensive Developments in Hematology in Daily Practice 

Understanding the Importance of Knowing Your MCV Normal Range 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research identifies nearly 200 potential breast carcinogens in food packaging materials

2.

Study suggests exercise could reduce breast cancer recurrence

3.

Updates from the 2022 WHO classification of kidney epithelial tumors

4.

A protein with new anticancer activity has been identified

5.

The risk of lung cancer recurrence is linked to hypoxemia brought on by sleep apnea.

1.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

2.

Transformative Frameworks in Oncology for Better Care

3.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

4.

The Benefits and Risks of Thrombolytics: A Comprehensive Guide 

5.

What is Red Cell Distribution Width and Why Should You Care?

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

3.

Navigating the Complexities of Ph Negative ALL - Part IX

4.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

5.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot